<?xml version="1.0" encoding="UTF-8"?>
<p>Silymarin has also been known to increase protein synthesis in hepatocytes [
 <xref rid="B57-molecules-25-05905" ref-type="bibr">57</xref>]. Owing to its phenolic existence, it can give electrons to stabilize free radicals and reactive oxygen molecules [
 <xref rid="B63-molecules-25-05905" ref-type="bibr">63</xref>]. Silymarin also modulates intracellular glutathione, which inhibits membranes from lipid peroxidation [
 <xref rid="B64-molecules-25-05905" ref-type="bibr">64</xref>]. Silymarin also has antiviral effects as it affects RNA and DNA synthesis [
 <xref rid="B65-molecules-25-05905" ref-type="bibr">65</xref>]. Eurasil 85 is a strong oral bioavailable silymarin formulation with potent antioxidant activity are found in clinical studies, and co-administration with several antiretrovirals has been shown to be safe [
 <xref rid="B66-molecules-25-05905" ref-type="bibr">66</xref>,
 <xref rid="B67-molecules-25-05905" ref-type="bibr">67</xref>]. Although the use of silymarin in the management of hepatic dysfunctions remains a historical interest, its utility in the management of SAR-COV-2 induced liver dysfunction should be explored [
 <xref rid="B68-molecules-25-05905" ref-type="bibr">68</xref>].
</p>
